Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-41.79M
Near historical average
Average (9y)
$-39.19M
Historical baseline
Range
High:$-4.76M
Low:$-100.17M
CAGR
+27.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-41.79M | -15.8% |
| 2023 | $-36.10M | +3.9% |
| 2022 | $-37.56M | +22.1% |
| 2021 | $-48.24M | +51.8% |
| 2020 | $-100.17M | -106.7% |
| 2019 | $-48.46M | -49.7% |
| 2018 | $-32.37M | -13.6% |
| 2017 | $-28.50M | -104.7% |
| 2016 | $-13.92M | -192.4% |
| 2015 | $-4.76M | - |